These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 19389436

  • 1. siRNA vs. shRNA: similarities and differences.
    Rao DD, Vorhies JS, Senzer N, Nemunaitis J.
    Adv Drug Deliv Rev; 2009 Jul 25; 61(9):746-59. PubMed ID: 19389436
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.
    Rao DD, Senzer N, Cleary MA, Nemunaitis J.
    Cancer Gene Ther; 2009 Nov 25; 16(11):807-9. PubMed ID: 19713999
    [Abstract] [Full Text] [Related]

  • 4. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
    Aigner A.
    Expert Opin Biol Ther; 2009 Dec 25; 9(12):1533-42. PubMed ID: 19769540
    [Abstract] [Full Text] [Related]

  • 5. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS, Nemunaitis J.
    Expert Rev Anticancer Ther; 2007 Mar 25; 7(3):373-82. PubMed ID: 17338656
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enzymatically prepared RNAi libraries.
    Buchholz F, Kittler R, Slabicki M, Theis M.
    Nat Methods; 2006 Sep 25; 3(9):696-700. PubMed ID: 16929314
    [Abstract] [Full Text] [Related]

  • 8. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S, Benter I.
    Adv Drug Deliv Rev; 2007 Mar 30; 59(2-3):164-82. PubMed ID: 17481774
    [Abstract] [Full Text] [Related]

  • 9. Primer extension-based method for the generation of a siRNA/miRNA expression vector.
    Gou D, Zhang H, Baviskar PS, Liu L.
    Physiol Genomics; 2007 Nov 14; 31(3):554-62. PubMed ID: 17804605
    [Abstract] [Full Text] [Related]

  • 10. Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
    Rao DD, Maples PB, Senzer N, Kumar P, Wang Z, Pappen BO, Yu Y, Haddock C, Jay C, Phadke AP, Chen S, Kuhn J, Dylewski D, Scott S, Monsma D, Webb C, Tong A, Shanahan D, Nemunaitis J.
    Cancer Gene Ther; 2010 Nov 14; 17(11):780-91. PubMed ID: 20596090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimization of shRNA inhibitors by variation of the terminal loop sequence.
    Schopman NC, Liu YP, Konstantinova P, ter Brake O, Berkhout B.
    Antiviral Res; 2010 May 14; 86(2):204-11. PubMed ID: 20188764
    [Abstract] [Full Text] [Related]

  • 13. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E, Boese Q, Khvorova A, Karpilow J.
    Methods Mol Biol; 2008 May 14; 442():45-63. PubMed ID: 18369777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Small silencing RNAs: state-of-the-art.
    Grimm D.
    Adv Drug Deliv Rev; 2009 Jul 25; 61(9):672-703. PubMed ID: 19427885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. RNA interference in mice.
    Kühn R, Streif S, Wurst W.
    Handb Exp Pharmacol; 2007 Jul 25; (178):149-76. PubMed ID: 17203655
    [Abstract] [Full Text] [Related]

  • 19. Prospects of RNA interference therapy for cancer.
    Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC.
    Gene Ther; 2006 Mar 25; 13(6):464-77. PubMed ID: 16341059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.